Acid Secretion, 1932-92: Advances, Adaptations, and Paradoxes

References

• Arey L B. Development anatomy. WB Saunders, Philadelphia 1965; 248
   Google Scholar
• Marino L R. Development of gastric secretory function. Fetal and neonatal physiology, R A Polin, W W Fox. WB Saunders, Philadelphia 1991; Vol. 2
   Google Scholar
• Johnson L R. Regulation of gastrointestinal mucosal growth. Physiol Rev 1988; 68: 456–502
   PubMed Web of Science ®Google Scholar
• Waalewijn R A, Meuwissen S GM, Pals G, Hoppsmit E CM. Localization pepsinogen (A&C) and cellular differentiation of pepsinogen-synthesizing cells in the human gastric mucosa. Eur J Cell Biol 1991; 54: 55–60
   PubMed Web of Science ®Google Scholar
• Euler A R, Byrne W J, Cousins L M, et al. Increased serum gastrin concentrations and gastric acid hyposecretion in the immediate newborn period. Gastroenterology 1977; 72: 1271–3
   PubMed Web of Science ®Google Scholar
• Hirschowitz B I. Electrolytes in human gastric secretion–observations and a theory. Am J Dig Dis NS 1961; 6: 199–228
   PubMedGoogle Scholar
• Bralow S P, Komarov S A. Parietal cell mass and distribution in stomachs of Wistar rats. Am J Physiol 1962; 203: 550–2
   PubMed Web of Science ®Google Scholar
• Harada T, Hyman P E, Everett S, Ament M E. Meal-stimulated gastric acid secretion in infants. J Pediatr 1984; 105: 534–8
   Google Scholar
• Guelrud M, Mujica C, Jaen D, Machuca J, Essenfeld E. Prevalence of Helicobacter pylori in neonates and young infants undergoing ERCP for diagnosis of neonatal cholestasis. Gastroenterology 1992; 102: A77
   Google Scholar
• Helander H F. The normal gastric mucosa. The stomach, S Gustavson, D Kumar, D Y Graham. Churchill Livingstone, Edinburgh 1992; 1–19
   Google Scholar
• Code C F. Histamine and gastric secretion. Histamine, G EW Wolstenholme, C M O'Connor. Little Brown, Boston 1961; 189–219
   Google Scholar
• Walsh J H. Gas-troduodenal disease, M H Sleisenger, J S Fordtran. Saunders, Philadelphia 1973; 150
   Google Scholar
• Lorenz W, . Stimulus secretion coupling in the gastrointestinal tract, R M Case, H Goebel, et al. MTP Press, Lancaster 1975; 175
   Google Scholar
• Feldman M. Gas-troduodenal disease. 4th ed, M H Sleisinger, J S Fordtran. Saunders, Philadelphia 1989; 717
   Google Scholar
• Sachs G, Hersey S J. Acid secretion by the parietal cell. The stomach, S Gustavson, D Kumar, D Y Graham. Churchill Livingstone, Edinburgh 1992; 41–52
   Google Scholar
• Böttcher G, Häkanson R, Nilsson G, Seensalu R, Sundler F. Effects of long-term hypergastrinaemia on the ultrastructure of enterochromaffin-like cells in the stomach of the rat, hamster and guinea pig. Cell Tiss Res 1989; 256: 247–57
   PubMed Web of Science ®Google Scholar
• Komarov S A. Gastrin. Proc Soc Exp Biol NY 1938; 38: 514
   Google Scholar
• Edkins J S. On the chemical mechanism of gastric secretion. Proc R Soc Lond [Biol] 1905; 76: 376
   Google Scholar
• Gregory R A. Secretory mechanisms of the gastrointestinal tract. Arnold, London 1962
   Google Scholar
• Crean G P, Marshall M W, Rumsey R DE. Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats. Gastroenterology 1969; 57: 147–55
   PubMed Web of Science ®Google Scholar
• Cox A J. Stomach size and its relation to chronic peptic ulcer. Arch Pathol 1952; 54: 497–522
   Google Scholar
• Naik S R, Bajaj S C, Goyal R K, Gupta D N, Chuttani H K. Parietal cell mass in healthy human stomach. Gastroenterology 1971; 61: 682–5
   PubMed Web of Science ®Google Scholar
• Card W I, Marks I N. The relationship between the acid output of the stomach following ‘maximal’ histamine stimulation and the parietal cell mass. Clin Sc 1960; 19: 147–63
   PubMed Web of Science ®Google Scholar
• Cheng F CY, Lam S K, Ong G B. Maximum acid output to graded doses of pentagastrin and its relation to parietal cell mass in Chinese patients with duodenal ulcer. Gut 1977; 18: 827–32
   PubMed Web of Science ®Google Scholar
• Marks I N, Komarov S A, Shay H. Maximal acid secretory response to histamine and its relation to parietal cell mass in the dog. Am J Physiol 1960; 199: 579–88
   PubMed Web of Science ®Google Scholar
• Crane E E, Davies R E. Chemical and electrical energy relations for the stomach. Biochem J 1951; 49: 169–75
   PubMed Web of Science ®Google Scholar
• Vanzant F R, Alvarez W C, Eusterman G B, Dunn H L, Berkson J. The normal range of gastric acidity from youth to old age– an analysis of 3746 records. Arch Intern Med 1932; 49: 345–59
   Google Scholar
• Bockus H L, Bank J, Willard J H. Achlorhydria. Am J Med Sci 1932; 184: 185–201
   Google Scholar
• Bloomfield A L, Pollard W S. Gastric acidity. Mac-millan, New York 1933
   Google Scholar
• Vanzant F R, Alvarez W C, Berkson J, Eusterman G B. Changes in gastric acidity in peptic ulcer, cholecystitus and other diseases–analysed with the help of a new and accurate technique. Arch Intern Med 1933; 52: 616–31
   Google Scholar
• Baron J H. Lean body mass, gastric ulcer and peptic ulcer. Gut 1969; 10: 637–42
   PubMed Web of Science ®Google Scholar
• Grossman M I, Kirsner J B, Gillespie I E. Basal and histalog stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer. Gastroenterology 1963; 45: 14–26
   PubMed Web of Science ®Google Scholar
• Kirsner J B, Ford H. The gastric secretory response to Histalog: One-hour basal and Histalog secretion in normal persons and in patients with duodenal ulcer and gastric ulcer. J Lab Clin Med 1955; 46: 307–11
   PubMed Web of Science ®Google Scholar
• Wormsley K G, Grossman M I. Maximal histalog test in control subjects and patients with peptic ulcer. Gut 1965; 6: 427–35
   PubMed Web of Science ®Google Scholar
• Cleator I GM, Stoller J L, Nunn P N, Holubitsky I B, Johnstone F RC, Harrison R C. Discriminant analysis of data in ulcer and non-ulcer populations. Dig Dis Sci 1973; 18: 301–10
   Google Scholar
• Goldschmiedt M, Barnett C, Schwartz B, Karnes W E, Redfern J S, Feldman M. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991; 101: 977–90
   PubMed Web of Science ®Google Scholar
• Hirschowitz B I, Lanas A. Effect of aging on gastric acid and pepsin secretion–cross sectional studies in DU and non-DU humans and longitudinal studies in fistula dogs. Gastroenterology 1992; 102: A83
   Google Scholar
• Kekki M, Samloff I M, Ihamaki T, Varis K, Siurala M. Age- and sex-related behaviour of gastric acid secretion at the population level. Scand J Gastroenterol 1982; 17: 737–43
   PubMed Web of Science ®Google Scholar
• Trey G, Marks I N, Novis B, et al. Does acid secretion change with aging? A 30-year follow-up study. S Afr Med J 1991; 80: A54
   Google Scholar
• Fiddian-Green R G, Marks I N, Bank S, Louw J H. Maximum acid output and position of peptic ulcers. Lancet 1976; 2: 1370
   PubMed Web of Science ®Google Scholar
• Stevens C E. Comparative physiology of the vertebrate digestive system. Cambridge University Press, Cambridge 1988
   Google Scholar
• Hirschowitz B I. Control of pepsinogen secretion. Curr Opin Gastroenterol 1991; 7: 863–9
   Web of Science ®Google Scholar
• Pounder R E, Prewett E J. Gastric secretion in health and disease. The stomach, S Gustavson, D Kumar, D Y Graham. Churchill Livingstone, Edinburgh 1992; 53–79
   Google Scholar
• Einhorn M. Verstopfung und Diarrhoea als Folgesustande mancher Magenerkrankung. Arch Verdaungskr 1898; 3: 139
   Google Scholar
• Hurst A F. The clinical importance of achlorhydria. Br Med J 1934; 2: 665–9
   PubMedGoogle Scholar
• Carlsson E, Larsson H, Mattsson H, Ryberg B, Sundell B. Pharmacology and toxicity of omeprazole–with special reference to the effects on the gastric mucosa. Scand J Gastroenterol 1986; 21: 31–3, Suppl 118
   PubMed Web of Science ®Google Scholar
• Berkowitz I, Marks I N, Modlin I M. Low acid, high gastrin–a signal sequence for gastric endocrine neoplasia. Eur J Gastroenterol Hepatol 1991; 3: 189–91
   Web of Science ®Google Scholar
• Hyman P E, Abrahams C, Garvey T Q. Ranitidine tachyphylaxis. Gastroenterology 1985; 88: A1426
   Web of Science ®Google Scholar
• Nwokolo C U, Smith J TL, Gavey C, Sawyer A, Pounder R E. Tolerance during 29 days of conventional dosing with cimet-idine, nizatidine, famotidine or ranitidine. Alim Pharmacol Ther 1990; 45: 29–46
   Google Scholar
• Wilder-Smith C H, Halter F, Ernst T, et al. Loss of acid suppression during dosing with H2-receptor antagonists. Alim Pharmacol Ther 1990; 4: 15–27, Suppl 1
   PubMed Web of Science ®Google Scholar
• Saunders J HB, Wormsley K G. Long-term effects and aftereffects of treatment of duodenal ulcer with metiamide. Lancet 1977; 1: 765–7
   PubMed Web of Science ®Google Scholar
• Marks I N. A sceptical view of medical treatment. Topics of gastroenterology 7, S C Truelove, C P Willoughby. Blackwell, Oxford 1979; 111–30
   Google Scholar
• Aadland E, Berstad A. Parietal and chief cell sensitivity to histamine and pentagastrin stimulation before and after treatment with cimetidine in healthy subjects. Scand J Gastroenterol 1979; 14: 933–8
   PubMed Web of Science ®Google Scholar
• Frislid K, Aadland E, Berstad A. Augmented post-prandial gastric secretion due to exposure to ranitidine in healthy subjects. Scand J Gastroenterol 1986; 21: 119–22
   PubMed Web of Science ®Google Scholar
• Nwokolo C U, Smith J TL, Sawyer A M, Pounder R E. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2-receptor antagonist. Gut 1991; 32: 1455–60
   PubMed Web of Science ®Google Scholar
• Jones D B, Howden C W, Burget D W, Silletti C, Hunt R H. Alteration in H2-receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2-receptor antagonist. Gut 1988; 29: 890–3
   PubMed Web of Science ®Google Scholar
• Fullarton G M, McLaughlan G, MacDonald A, Crean G P, McColl K EL. Rebound nocturnal hypersecretion after 4 weeks H,-antagonist therapy. Gut 1989; 30: 449–54
   PubMed Web of Science ®Google Scholar
• Marks I N, Young G O, Tigler-Wybrandi N A, Bridger S A, Newton K A. Acid secretory response and parietal cell sensitivity in patients with duodenal ulcer before and after treatment with sucralfate or ranitidine. Am J Med 1989; 86: 145–7, Suppl 6A
   PubMed Web of Science ®Google Scholar
• Johnston D A, Marks I N, Young G O, Tigler-Wybrandi N A, Bridger S A. Duodenal ulcer healing and acid secretory responses to modified sham feeding and pentagastrin stimulation. Aliment Pharmacol Ther 1990; 4: 403–10
   PubMed Web of Science ®Google Scholar
• Kummer A F, Johnston D A, Marks I N, Tigler-Wybrandi N A, Bridger S A, Young G O. Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine. Gut 1992; 33: 175–8
   PubMed Web of Science ®Google Scholar
• Marks I N, Johnston D A, Young G O. Acid secretory changes and early relapse following duodenal ulcer healing with sucralfate, ranitidine, antacids or omeprazole. Mechanism of peptic ulcer healing. Falk Symposium 59, F Halter, A Garner, G NJ Tytgat. Kluwer Academic Publishers, Dordrecht 1991; 273–81
   Google Scholar
• Yanaka A, Muto H. Increased parietal cell responsiveness to tetragastrin in patients with recurrent duodenal ulcer. Dig Dis Sci 1988; 33: 1459–65
   PubMed Web of Science ®Google Scholar
• Marks I N. Sucralfate: efficacy & basis for therapy. Ulcer disease–investigation and basis for therapy, E A Swabb, S Szabo. Marcel Dekker Inc., New York 1991; 263–85
   Google Scholar
• Simon B, Swarovsky B, Eissele R, Arnold R. Expression of the gastric proton pump H+K+ATPase subunits during omeprazole-induced achlorhydria. Gastroenterology 1992; 102: A165
   Google Scholar
• Sharma B, Axelson M, Pounder R E, et al. Acid secretory capacity and plasma gastrin concentration after administration of omeprazole to normal subjects. Aliment Pharmacol Ther 1987; 1: 67–76
   PubMedGoogle Scholar
• Prewett E J, Hudson M, Nwokolo C U, Sawyerr A M, Pounder R E. Return of nocturnal intragastric acidity after dosing with either ranitidine or omeprazole. Gastroenterology 1991; 100: 873–7
   PubMed Web of Science ®Google Scholar
• Walsh J H, Sytnik B, Maxwell V, et al. Reversibility of plasma gastrin changes induced by omeprazole or ranitidine in man. Am J Gastroenterol 1988; 83: 1042(A)
   Web of Science ®Google Scholar
• Yokota H, Yanaka A, Muto H. Effect of H+K+-dependent ATPase inhibitor (omeprazole) on parietal cell sensitivity in duodenal ulcer patients. Gastroenterol Int 1988; 480A, Suppl 1
   Google Scholar
• Wood E C, Logan L H. Optimal dose of oral omeprazole for maximal 24-hour decrease of intragastric acidity. Gut 1984; 25: 957–64
   PubMed Web of Science ®Google Scholar
• Johnston D A, Marks I N, Young G O, Tigler-Wybrandi N A, Bridger S A, Zak J. Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate and Maalox. Am J Med 1991; 91: 91S–4S
   PubMed Web of Science ®Google Scholar
• Marks I N, Young G O, Winter T, et al. Duration of acid inhibition after withdrawal of omeprazole treatment in DU patients in remission. S Afr Med J 1992; 82: 42(A)
   Google Scholar
• Karam S M, Crothers J M, Forte J G. Are parietal cells vulnerable to omeprazole?. Gastroenterology 1992; 102: A93
   Google Scholar
• Inokuchi H, Kawai T, Hattori T, Kawai K. Omeprazole causes parietal cell damage, DNA synthesis and cellular proliferation in rat oxyntic mucosa. Eur J Gastroenterol Hepatol 1992; 4: 207–14
   Web of Science ®Google Scholar
• Armstrong D, Viani F, Siegrist H, et al. Does omeprazole increase gastric bacterial counts, nitrite or total nitroso compound (NOC) in healthy subjects. Gastroenterology 1992; 102: A34
   Google Scholar
• Ragins H, Wincze F, Liu S M, Dittbrenner M. The original and survival of gastric parietal cells in the mouse. Anat Rec 1968; 162: 99–110
   PubMedGoogle Scholar
• Karam S M. Origin, migration and fate of mouse parietal cells. Gastroenterology 1990; 98: A659
   Google Scholar
• Boyd E JS, Penston J G, Wormsley K G. Factors other than inhibition of acidity which are involved in ulcer healing. Mechanisms of peptic ulcer healing. Falk Symposium 59, F Halter, A Garner, G NJ Tytgat. Kluwer, Dordrecht 1991; 203–29
   Google Scholar
• Hirschowitz B I. Pepsin in the pathogenesis of peptic ulcer. Mechanisms of peptic ulcer healing. Falk Symposium 59, F Halter, A Garner, G NJ Tytgat. Kluwer, Dordrecht 1991; 183–94
   Google Scholar
• Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y. Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 1991; 214: 414–27
   PubMed Web of Science ®Google Scholar